PIMA541997
Lodelcizumab Recombinant Human Monoclonal Antibody, Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIMA541997-Each-of-1 | In Stock | ₹ 44,020.62 |
PIMA541997 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 44,020.62
GST (18%): ₹ 7,923.712
Total Price: ₹ 51,944.332
Antigen
Lodelcizumab
Classification
Recombinant Monoclonal
Conjugate
Unconjugated
Gene Alias
LGT209; NVP-LGT209
Immunogen
Human PCSK9
Quantity
100 μg
Primary or Secondary
Primary
Content And Storage
-20° C, Avoid Freeze/Thaw Cycles
Form
Liquid
Target Molecule
Chemical
Applications
ELISA, SDS-Page
Concentration
1 mg/mL
Formulation
PBS with no preservative; pH 7.4
Host Species
Human
Purification Method
Protein A
Regulatory Status
RUO
Target Species
Chemical
Product Type
Antibody
Isotype
IgG1 κ
Related Products
Description
- Endotoxin level < 0.01EU/μg by LAL method Use a manual defrost freezer and avoid repeated freeze thaw cycles
- Store at 2 to 8 °C for one week
- Store at -20 to -80 °C for twelve months from the date of receipt
- Lodelcizumab is a biosimilar that targets PCSK9
- PCSK9 is a proprotein convertase belonging to the proteinase K subfamily of the secretory subtilase family
- This protein is synthesized as a soluble zymogen that undergoes autocatalytic intramolecular processing in the endoplasmic reticulum
- The protein may function as a proprotein convertase
- The protein plays a role in cholesterol homeostasis and may have a role in the differentiation of cortical neurons.
Compare Similar Items
Show Difference
Antigen: Lodelcizumab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: LGT209; NVP-LGT209
Immunogen: Human PCSK9
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Target Molecule: Chemical
Applications: ELISA, SDS-Page
Concentration: 1 mg/mL
Formulation: PBS with no preservative; pH 7.4
Host Species: Human
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Isotype: IgG1 κ
Antigen:
Lodelcizumab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
LGT209; NVP-LGT209
Immunogen:
Human PCSK9
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Target Molecule:
Chemical
Applications:
ELISA, SDS-Page
Concentration:
1 mg/mL
Formulation:
PBS with no preservative; pH 7.4
Host Species:
Human
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Isotype:
IgG1 κ
Antigen: Idarucizumab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: aDabi-Fab; dabigatran; dabigatran etexilate mesylate
Immunogen: Pradaxa (Dabigatran Etexilate Mesylate) dabigatran etexilate mesylate
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Target Molecule: Chemical
Applications: ELISA, SDS-Page
Concentration: 2.53 mg/mL
Formulation: 30mM histidine with 0.06% Tween 80, 10% sucrose and no preservative; pH 5.8
Host Species: Human
Purification Method: Protein L
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Isotype: IgG1 F(ab) κ
Antigen:
Idarucizumab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
aDabi-Fab; dabigatran; dabigatran etexilate mesylate
Immunogen:
Pradaxa (Dabigatran Etexilate Mesylate) dabigatran etexilate mesylate
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Target Molecule:
Chemical
Applications:
ELISA, SDS-Page
Concentration:
2.53 mg/mL
Formulation:
30mM histidine with 0.06% Tween 80, 10% sucrose and no preservative; pH 5.8
Host Species:
Human
Purification Method:
Protein L
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Isotype:
IgG1 F(ab) κ
Antigen: Dinutuximab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: MAb-14.18; MOAB Ch14.18
Immunogen: Human ganglioside GD2
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Target Molecule: Chemical
Applications: ELISA, SDS-Page
Concentration: 1.3 mg/mL
Formulation: PBS with no preservative; pH 7.4
Host Species: Human
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Isotype: IgG1 κ
Antigen:
Dinutuximab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
MAb-14.18; MOAB Ch14.18
Immunogen:
Human ganglioside GD2
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Target Molecule:
Chemical
Applications:
ELISA, SDS-Page
Concentration:
1.3 mg/mL
Formulation:
PBS with no preservative; pH 7.4
Host Species:
Human
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Isotype:
IgG1 κ
Antigen: Codrituzumab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: RG7686; RO5137382
Immunogen: Human GPC3
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Target Molecule: Chemical
Applications: ELISA, SDS-Page
Concentration: 1.1 mg/mL
Formulation: PBS with no preservative; pH 7.4
Host Species: Human
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Isotype: IgG1 κ
Antigen:
Codrituzumab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
RG7686; RO5137382
Immunogen:
Human GPC3
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Target Molecule:
Chemical
Applications:
ELISA, SDS-Page
Concentration:
1.1 mg/mL
Formulation:
PBS with no preservative; pH 7.4
Host Species:
Human
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Isotype:
IgG1 κ